Neonatal Jaundice Clinical Trial
Official title:
Use of "BUBOLight®" Device as an Innovative Phototherapy Device for the Treatment of Newborn's Jaundice. A Monocentric, Descriptive Pilot Study, for the Feasibility, Safety and Tolerance of the BUBOLight® Device
About 50% of full-term newborns and 80% of premature infants develop jaundice which is due to hyperbilirubinemia. In the majority of cases, jaundice disappears naturally without treatment within three weeks of birth, but the bilirubin level may remain too high, which can lead to a serious neurological disease: kernicterus. To avoid this, a therapeutic management must be instituted, and in some cases, one or more phototherapy sessions (PT) may be prescribed. The aim of this trial is to evaluate the safety and level of satisfaction of parents and healthcare team with one innovative device for phototherapy BUBOLight® included two removable strips of luminous textile incorporating optical fibers. 10 newborns requiring phototherapy, will be illuminated during four hours in one session of PT Bilirubin levels is taken at the start of phototherapy H0 and Controls are made at H+6 hours.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02222805 -
Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment
|
N/A | |
| Completed |
NCT01622699 -
Implementation of a Transcutaneous Bilirubinometer
|
N/A | |
| Completed |
NCT00692224 -
Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06080971 -
Persistent Neonatal Jaundice on Neonates and Childern
|
||
| Recruiting |
NCT06075290 -
the Difference of Follow-up Methods of Neonatal Jaundice
|
||
| Recruiting |
NCT05955144 -
Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones
|
N/A | |
| Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
| Completed |
NCT03306004 -
Neonatal Jaundice: Knowledge, Attitudes and Practices of Mothers and Medical Trainees and Providers in and Around Ogbomosho
|
N/A | |
| Completed |
NCT02774434 -
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age
|
N/A | |
| Terminated |
NCT05365399 -
Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
|
N/A | |
| Recruiting |
NCT03933423 -
Home Based Phototherapy for Neonatal Jaundice
|
N/A | |
| Recruiting |
NCT06087874 -
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
|
Phase 2 | |
| Recruiting |
NCT06399146 -
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
|
N/A | |
| Recruiting |
NCT03183986 -
Comparison of the Efficacy of Phototherapy Using Blue LED's With Wavelength 478 vs. 459 nm.
|
N/A | |
| Withdrawn |
NCT00917007 -
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
|
||
| Completed |
NCT06227624 -
Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia
|
Phase 3 | |
| Completed |
NCT04418180 -
Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
|
N/A | |
| Completed |
NCT04433923 -
Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants
|
N/A | |
| Completed |
NCT06386731 -
Continuous Versus Intermittent Phototherapy in Treatment of Neonatal Jaundice
|
N/A | |
| Not yet recruiting |
NCT05475223 -
End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis
|
N/A |